It’s “a move away from a one-size-fits-all framework for Alzheimer’s disease.” ...

Scientists at the Buck Institute for Research on Aging, along with collaborators at UC San Francisco, have discovered that APOE4, the most common genetic risk factor for Alzheimer's disease, causes ...

Mahmood’s interest in neuroscience led her to Indianapolis in summer 2025, where she helped with student research into early ...

Opting for the higher-than-standard dose of the flu vaccine may help lower Alzheimer's risk by more than half in adults over ...

Alzheimer’s isn’t just one problem—it’s a tangled mix of biology, aging, and overall health. That’s why drugs targeting a single factor have fallen short, even as new treatments show modest benefits.

Scientists at the Buck Institute for Research on Aging, along with collaborators at UC San Francisco, have discovered that ...

With a NOK 40 million (approx. €3.5 million) grant, Professor Srdjan Djurovic at the University of Oslo aims to identify early blood-based biomarkers that can predict who is at increased risk of ...

I understand that there is treatment for the beginning stages of Alzheimer’s disease that can stave off serious decline. There are also new tests to determine if a person is in the beginning stages, ...

The OpenAI Foundation announced a $100 million grant for Alzheimer's research earlier this week, in partnership with two Bay Area-based research institutes.

A new $30 million Brain Health Center at USC in Columbia will be a magnet for advanced diagnosis and treatment of Alzheimer’s ...

A Paris raffle is offering a Picasso for €100 a ticket, with proceeds expected to raise millions for Alzheimer’s research.